{"data":[{"accessionNo":"0001829126-26-011443","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-10-16","reportingPerson":"Yao Yun","reportingCik":"0002120637","personType":"IN","sharesOwned":41991000,"percentOfClass":27.34,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-011445","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-10-16","reportingPerson":"Chenhao Xu","reportingCik":null,"personType":"IN","sharesOwned":38895000,"percentOfClass":25.325,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-011445","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-10-16","reportingPerson":"Sino Lion Ventures Ltd","reportingCik":"0002120638","personType":"CO","sharesOwned":38895000,"percentOfClass":25.325,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-011444","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-10-16","reportingPerson":"Dai Junyi","reportingCik":"0002022463","personType":"IN","sharesOwned":11250000,"percentOfClass":7.325,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-011386","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-10-16","reportingPerson":"Yang Ting","reportingCik":"0002120636","personType":"IN","sharesOwned":9948173,"percentOfClass":6.48,"filedAt":"2026-10-21","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-006949","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-24","reportingPerson":"Yao Yun","reportingCik":"0002120637","personType":"IN","sharesOwned":41991000,"percentOfClass":31.51,"filedAt":"2026-06-26","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-006953","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-24","reportingPerson":"Sino Lion Ventures Ltd","reportingCik":"0002120638","personType":"CO","sharesOwned":38895000,"percentOfClass":29.19,"filedAt":"2026-06-26","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-006953","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-24","reportingPerson":"Chenhao Xu","reportingCik":null,"personType":"IN","sharesOwned":38895000,"percentOfClass":29.19,"filedAt":"2026-06-26","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-006950","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-24","reportingPerson":"Yang Ting","reportingCik":"0002120636","personType":"IN","sharesOwned":11250000,"percentOfClass":8.44,"filedAt":"2026-06-26","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-006951","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-24","reportingPerson":"Dai Junyi","reportingCik":"0002022463","personType":"IN","sharesOwned":11250000,"percentOfClass":8.44,"filedAt":"2026-06-26","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"Yao Yun","reportingCik":"0002120637","personType":"IN","sharesOwned":41991000,"percentOfClass":37.1,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"SINO LION VENTURES Ltd","reportingCik":"0002120638","personType":"PN","sharesOwned":38895000,"percentOfClass":34.3,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"Xu Chenhao","reportingCik":null,"personType":"IN","sharesOwned":38895000,"percentOfClass":34.3,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"Dai Junyi","reportingCik":"0002022463","personType":"IN","sharesOwned":11250000,"percentOfClass":9.9,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"Yang Ting","reportingCik":"0002120636","personType":"IN","sharesOwned":11250000,"percentOfClass":9.9,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-004104","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-28","reportingPerson":"Deng Lina","reportingCik":"0002120635","personType":"IN","sharesOwned":5550000,"percentOfClass":4.9,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"YA II PN, Ltd.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"YA Global Investments II (U.S.), LP","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Yorkville Advisors Global, LP","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Yorkville Advisors Global II, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"YAII GP, LP","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"YAII GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Mark Angelo","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001104659-26-039973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"SC-Sigma Global Partners, LP","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Yao Yun","reportingCik":"0002120637","personType":"IN","sharesOwned":41991000,"percentOfClass":37.8,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"SINO LION VENTURES Ltd","reportingCik":"0002120638","personType":"PN","sharesOwned":38895000,"percentOfClass":35,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Xu Chenhao","reportingCik":null,"personType":"IN","sharesOwned":38895000,"percentOfClass":35,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Dai Junyi","reportingCik":"0002022463","personType":"IN","sharesOwned":11250000,"percentOfClass":10.1,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Yang Ting","reportingCik":"0002120636","personType":"IN","sharesOwned":11250000,"percentOfClass":10.1,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002858","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Deng Lina","reportingCik":"0002120635","personType":"IN","sharesOwned":5550000,"percentOfClass":5,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-002642","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":"45339J105","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-23","reportingPerson":"Lazar David E.","reportingCik":"0001932843","personType":"IN","sharesOwned":2064000,"percentOfClass":47.93,"filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001829126-26-001810","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics Inc.","ticker":"INDP","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2026-02-26","reportingPerson":"Lazar David E.","reportingCik":"0001932843","personType":"IN","sharesOwned":111000000,"percentOfClass":98,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001493152-25-029594","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-22","reportingPerson":"Jeffery A. Meckler","reportingCik":"0001506916","personType":"IN","sharesOwned":273103,"percentOfClass":12.7,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"},{"accessionNo":"0001493152-25-029593","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001857044","issuerName":"Indaptus Therapeutics, Inc.","ticker":"INDP","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-22","reportingPerson":"Newman Michael James","reportingCik":"0001876315","personType":"IN","sharesOwned":115552,"percentOfClass":5.4,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/indp"}],"updatedAt":"2026-11-03T18:36:00.308Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/indp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}